Key Metrics
CiteScore 

7.1
Impact Factor 

10 - 15
Scite Index 

0.90 5-Year SI

SJR 

Q3Biochemistry, Genetics and Molecular Biology (all)

SNIP 

2.45
Recommended pre-submission checks
Powered by 

Topics Covered on Cell Reports Medicine
Cell Reports Medicine Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 5460 |
| Publication Time | 17 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2020 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in Cell Reports Medicine ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Cell Reports Medicine
High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial.
- 30 Jun 2026
- Cell reports. Medicine
A radiopharmaceutical enhances CAR T cells against radio-sensitive and radio-resistant neuroblastoma by tumor sensitization and TME remodeling.
- 23 Jun 2026
- Cell reports. Medicine
Commensal Cutibacterium acnes-derived indolelactic acid safeguards skin barrier function through the aryl hydrocarbon receptor.
- 23 Jun 2026
- Cell reports. Medicine
Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.
- 23 Jun 2026
- Cell reports. Medicine
Safety and efficacy of GZR18, a long-acting GLP-1 analog, in Chinese patients with type 2 diabetes: A randomized, double-blind, phase 1b/2a trial.
- 19 Jun 2026
- Cell reports. Medicine
Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes.
- 19 Jun 2026
- Cell reports. Medicine
High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial.
- 30 Jun 2026
- Cell reports. Medicine
A radiopharmaceutical enhances CAR T cells against radio-sensitive and radio-resistant neuroblastoma by tumor sensitization and TME remodeling.
- 23 Jun 2026
- Cell reports. Medicine
Commensal Cutibacterium acnes-derived indolelactic acid safeguards skin barrier function through the aryl hydrocarbon receptor.
- 23 Jun 2026
- Cell reports. Medicine
Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.
- 23 Jun 2026
- Cell reports. Medicine
Safety and efficacy of GZR18, a long-acting GLP-1 analog, in Chinese patients with type 2 diabetes: A randomized, double-blind, phase 1b/2a trial.
- 19 Jun 2026
- Cell reports. Medicine
Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes.
- 19 Jun 2026
- Cell reports. Medicine